Sajul, James G.
HRN: 25-63-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/10/2024
08/16/2024
IVT
4.5g
Q8
Pneumonia
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes